MedPath

Levalbuterol

These highlights do not include all the information needed to use LEVALBUTEROL INHALATION SOLUTION safely and effectively. See full prescribing information for LEVALBUTEROL INHALATION SOLUTION. LEVALBUTEROL inhalation solution, for inhalation useInitial U.S. Approval: 1999

Approved
Approval ID

97699821-81f8-4623-8504-e479c0f4b183

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2019

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levalbuterol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-953
Application NumberANDA090297
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levalbuterol
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 1, 2018
FDA Product Classification

INGREDIENTS (6)

SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
LEVALBUTEROL HYDROCHLORIDEActive
Quantity: 0.63 mg in 3 mL
Code: WDQ1526QJM
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levalbuterol - FDA Drug Approval Details